234 related articles for article (PubMed ID: 31945729)
1. circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252.
Zhang S; Cheng J; Quan C; Wen H; Feng Z; Hu Q; Zhu J; Huang Y; Wu X
Mol Ther Nucleic Acids; 2020 Mar; 19():718-730. PubMed ID: 31945729
[TBL] [Abstract][Full Text] [Related]
2. circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with FUS to stabilize FOXR2.
Liang YX; Zhang LL; Yang L
Mol Cell Biochem; 2023 Apr; 478(4):835-850. PubMed ID: 36107285
[TBL] [Abstract][Full Text] [Related]
3. Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis.
Liu G; Zhang Z; Song Q; Guo Y; Bao P; Shui H
Onco Targets Ther; 2020; 13():9497-9511. PubMed ID: 33061434
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Circular RNA Hsa_circ_0000714 Can Regulate RAB17 by Sponging miR-370-3p to Reduce Paclitaxel Resistance of Ovarian Cancer Through CDK6/RB Pathway.
Guo M; Li S; Zhao X; Yuan Y; Zhang B; Guan Y
Onco Targets Ther; 2020; 13():13211-13224. PubMed ID: 33380810
[TBL] [Abstract][Full Text] [Related]
5. CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression.
Huang C; Qin L; Chen S; Huang Q
Anticancer Drugs; 2023 Mar; 34(3):395-404. PubMed ID: 36729852
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
Liu YY; Zhang LY; Du WZ
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
[TBL] [Abstract][Full Text] [Related]
8. CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR‑185‑5p/BMF axis.
Liu Y; Shen Z; Wei X; Gu L; Zheng M; Zhang Y; Cheng X; Fu Y; Lu W
Transl Oncol; 2023 Oct; 36():101746. PubMed ID: 37499410
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circTNPO3 Regulates Paclitaxel Resistance of Ovarian Cancer Cells by miR-1299/NEK2 Signaling Pathway.
Xia B; Zhao Z; Wu Y; Wang Y; Zhao Y; Wang J
Mol Ther Nucleic Acids; 2020 Sep; 21():780-791. PubMed ID: 32791450
[TBL] [Abstract][Full Text] [Related]
10. Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286.
Ni J; Xi X; Xiao S; Xiao X
Cancer Manag Res; 2021; 13():5573-5585. PubMed ID: 34285578
[TBL] [Abstract][Full Text] [Related]
11. SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a.
Lin H; Shen L; Lin Q; Dong C; Maswela B; Illahi GS; Wu X
Biomed Pharmacother; 2020 Mar; 123():109711. PubMed ID: 31884343
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194.
An J; Lv W; Zhang Y
Onco Targets Ther; 2017; 10():5377-5390. PubMed ID: 29180871
[TBL] [Abstract][Full Text] [Related]
13. Circ_0000231 promotes paclitaxel resistance in ovarian cancer by regulating miR-140/RAP1B.
Liu J; Wang H; Xiao S; Zhang S; Qi Y; Wang M
Am J Cancer Res; 2023; 13(3):872-885. PubMed ID: 37034216
[TBL] [Abstract][Full Text] [Related]
14. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA TUG1 Promotes Autophagy-Associated Paclitaxel Resistance by Sponging miR-29b-3p in Ovarian Cancer Cells.
Gu L; Li Q; Liu H; Lu X; Zhu M
Onco Targets Ther; 2020; 13():2007-2019. PubMed ID: 32189969
[TBL] [Abstract][Full Text] [Related]
16. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
17. Effect of circ MTHFD2 on resistance to pemetrexed in gastric cancer through regulating expression of miR-124.
Xu QY; Xie MJ; Huang J; Wang ZW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10290-10299. PubMed ID: 31841184
[TBL] [Abstract][Full Text] [Related]
18. hsa_circ_0061140 Knockdown Reverses FOXM1-Mediated Cell Growth and Metastasis in Ovarian Cancer through miR-370 Sponge Activity.
Chen Q; Zhang J; He Y; Wang Y
Mol Ther Nucleic Acids; 2018 Dec; 13():55-63. PubMed ID: 30236833
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis.
Huang B; Wei M; Hong L
Open Life Sci; 2021; 16(1):667-681. PubMed ID: 34250246
[TBL] [Abstract][Full Text] [Related]
20. Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway.
Du Z; Wang L; Xia Y
Cancer Cell Int; 2020 Nov; 20(1):572. PubMed ID: 33292255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
